O.K. so I don't have much time to get this post up. I actually HAVE a job and need to get back to work but this one looks SO goood to me and I am thinking of buying some. Have you EVER met a guy who cannot meet a stock he doesn't like?
Anyhow, came across this one on the most active this morning. I do not own any shares and USUALLY avoid the under $10 stocks because most aren't very financially solid. We did do well with EELN and I am open to checking....
LifeCell, according to Cnn.money, "is a bioengineering company engaged in the development and commercialization of tissue regeneration and cell preservation products." So if you don't have a biology/biochem background that is probably all Greek to you!
On April 24, 2003, per NYTimes on the Web, LifeCell Corporation reported their financial results for the first quarter ending March 31, 2003. They were solid: (although small), revenues were up 17% to $8.6 million and income was up 94% to $364,000 from $188,000 the prior year.
Morningstar.com picture is equally SWEET. Revenue growth has increased from $6.0 million in 1997, to $8.0 million in 1998, $12.7 million in 1999, $22.8 million, $27.8 million in 2001, and $34 million in 2002.
This little company is cash flow positive in 2002 from negative $2 million and negative $13 million in 2001 and 2000 respectively. Did that backward explanation confuse you? Anyhow they are improving their generation of cash.
They have $5.5 million in cash and $11.0 million in other current assets, compared to $4.9 million in current liabilities and only $1.0 million in long term debt. This is a BEAUTIFUL little company.
I don't own any shares....but I may look for funds to start a position TODAY.
Happy Wednesday. Drop me a line at firstname.lastname@example.org if you have any questions, comments, suggestions, or just kind words of encouragement. I have received a couple of emails suggesting we have a few readers out there who appreciate all of this....and thank you for writing.
Posted by bobsadviceforstocks at 10:33 AM CDT | Post Comment | Permalink